Fenlean
Fenlean (FLZ) is a tyrosine kinase Src inhibitor, a synthetic cyclic derivative of squamous amide from Annona glabra, with cytoprotective activity, which protects tyrosine hydroxylase function in a chronic MPTP/prostaglandin-type mouse model of Parkinson's disease.Fenlean inhibits the production of Aβ in the mitochondria, which may be useful in the study of age-related macular degeneration and Parkinson's disease. and Parkinson's.
Product Specifications
CAS Number
863193-70-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.5
Molecular Formula
C26H27NO6
Notes
Research use only, not for human use.
Receptor
Beta Amyloid | Src
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
